Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Aditxt, Inc.ADTX · Entity 8072 | Director | November 08, 2023 | November 13, 2023 |
| Altimmune, Inc.PIP · Entity 5349 | Director | January 20, 2017 | January 24, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Aditxt, Inc.
Report date November 08, 2023 · Filed November 13, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $5.01 · Expires 2033-11-08 | Direct | 470 |
Reported balance
After 2023-11-08 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-11-08 · Grant · Acquired 470 · Balance 470 F1: On November 8, 2023, the Reporting Person was granted options ("Options") to purchase up to 470 shares of the Registrant's common stock pursuant to the Registrant's 2021 Omnibus Equity Incentive Plan. The Options vest fully on the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: On November 8, 2023, the Reporting Person was granted options ("Options") to purchase up to 470 shares of the Registrant's common stock pursuant to the Registrant's 2021 Omnibus Equity Incentive Plan. The Options vest fully on the date of grant.
Altimmune, Inc.
Report date January 20, 2017 · Filed January 24, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, par value $0.0001 per shareSEC Table I · non-derivative | Direct | 197,700 |
Reported balance
After 2017-01-20 transaction · row 1
1 source rowRow 1 · 2017-01-20 · Exercise / conversion · Acquired 20,000 · Balance 197,700 |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.11 · Expires 2021-06-23 | Direct | 0 |
Reported balance
After 2017-01-20 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-01-20 · Exercise / conversion · Disposed 20,000 · Balance 0 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 08, 2023 Filed Nov 13, 2023 21:30 UTC | Aditxt, Inc. ADTX · Entity 8072 | GrantOptions (right to buy) · Derivative | 470 | $0.00 Strike: $5.01 | $0.00 |
DisclosureSEC source: 0001213900-23-086163 · ownership.xml · derivative · entry 1 Runge Jeffrey W. · CIK 0001479091 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 470 Underlying: Common Stock · 470 shares Expires 2033-11-08 F1 · derivative.exercise_date: On November 8, 2023, the Reporting Person was granted options ("Options") to purchase up to 470 shares of the Registrant's common stock pursuant to the Registrant's 2021 Omnibus Equity Incentive Plan. The Options vest fully on the date of grant. Read SEC document |
| September 29, 2021 Filed Oct 1, 2021 23:00 UTC | Aditxt, Inc. ADTX · Entity 8072 | GrantRestricted Stock Units · Derivative | 11,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-21-051197 · ownership.xml · derivative · entry 1 Runge Jeffrey W. · CIK 0001479091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,500 Underlying: Common Stock · 11,500 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ADTX common stock. F2 · derivative.exercise_date: 25% of the restricted stock units vest immediately, and the remaining 75% of the restricted stock units will vest in three equal quarterly instalments on the last date of each subsequent fiscal quarter, beginning December 31, 2021. F2 · derivative.expiration_date: 25% of the restricted stock units vest immediately, and the remaining 75% of the restricted stock units will vest in three equal quarterly instalments on the last date of each subsequent fiscal quarter, beginning December 31, 2021. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 21:38 UTC | Aditxt, Inc. ADTX · Entity 8072 | PurchaseCommon Stock | 3,000 | $2.94 | $8,819.70 |
DisclosureSEC source: 0001213900-21-030618 · ownership.xml · nonDerivative · entry 6 Runge Jeffrey W. · CIK 0001479091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,500 Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 21:38 UTC | Aditxt, Inc. ADTX · Entity 8072 | PurchaseCommon Stock | 2,000 | $2.93 | $5,860.00 |
DisclosureSEC source: 0001213900-21-030618 · ownership.xml · nonDerivative · entry 5 Runge Jeffrey W. · CIK 0001479091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,500 Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 21:38 UTC | Aditxt, Inc. ADTX · Entity 8072 | PurchaseCommon Stock | 2,000 | $2.93 | $5,860.00 |
DisclosureSEC source: 0001213900-21-030618 · ownership.xml · nonDerivative · entry 4 Runge Jeffrey W. · CIK 0001479091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 21:38 UTC | Aditxt, Inc. ADTX · Entity 8072 | PurchaseCommon Stock | 1,600 | $2.93 | $4,688.00 |
DisclosureSEC source: 0001213900-21-030618 · ownership.xml · nonDerivative · entry 3 Runge Jeffrey W. · CIK 0001479091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,500 Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 21:38 UTC | Aditxt, Inc. ADTX · Entity 8072 | PurchaseCommon Stock | 700 | $2.94 | $2,061.08 |
DisclosureSEC source: 0001213900-21-030618 · ownership.xml · nonDerivative · entry 2 Runge Jeffrey W. · CIK 0001479091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,900 Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 21:38 UTC | Aditxt, Inc. ADTX · Entity 8072 | PurchaseCommon Stock | 700 | $2.94 | $2,054.92 |
DisclosureSEC source: 0001213900-21-030618 · ownership.xml · nonDerivative · entry 1 Runge Jeffrey W. · CIK 0001479091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,200 Read SEC document |
| October 13, 2020 Filed Oct 15, 2020 10:14 UTC | Aditxt, Inc. ADTX · Entity 8072 | Disposition to issuerStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $1.94 | $0.00 |
DisclosureSEC source: 0001213900-20-031366 · ownership.xml · derivative · entry 1 Runge Jeffrey W. · CIK 0001479091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-10-13 F1 · derivative.exercise_date: 25% of the stock options vest immediately, and the remaining 75% of the stock options will vest in three equal quarterly installments on the last day of each subsequent fiscal quarter, beginning December 31, 2020. Read SEC document |
| October 13, 2020 Filed Oct 17, 2020 00:36 UTC Amendment | Aditxt, Inc. ADTX · Entity 8072 | GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $1.94 | $0.00 |
DisclosureSEC source: 0001213900-20-031868 · ownership.xml · derivative · entry 1 Runge Jeffrey W. · CIK 0001479091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-10-13 F1 · derivative.exercise_date: 25% of the stock options vest immediately, and the remaining 75% of the stock options will vest in three equal quarterly installments on the last day of each subsequent fiscal quarter, beginning December 31, 2020. Read SEC document |
| January 20, 2017 Filed Jan 24, 2017 16:30 UTC | Altimmune, Inc. PIP · Entity 5349 | Exercise / conversionStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $3.11 | $0.00 |
DisclosureSEC source: 0001144204-17-003608 · v457389_4.xml · derivative · entry 2 Runge Jeffrey W. · CIK 0001479091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2021-06-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 20, 2017 Filed Jan 24, 2017 16:30 UTC | Altimmune, Inc. PIP · Entity 5349 | Exercise / conversionCommon Stock, par value $0.0001 per share | 20,000 | $3.11 | $62,200.00 |
DisclosureSEC source: 0001144204-17-003608 · v457389_4.xml · nonDerivative · entry 1 Runge Jeffrey W. · CIK 0001479091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 28, 2016 Filed Nov 30, 2016 19:06 UTC | Altimmune, Inc. PIP · Entity 5349 | Exercise / conversionStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0001144204-16-137321 · v454222_4.xml · derivative · entry 2 Runge Jeffrey W. · CIK 0001479091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2026-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 28, 2016 Filed Nov 30, 2016 19:06 UTC | Altimmune, Inc. PIP · Entity 5349 | Exercise / conversionCommon Stock, par value $0.0001 per share | 20,000 | $2.20 | $44,000.00 |
DisclosureSEC source: 0001144204-16-137321 · v454222_4.xml · nonDerivative · entry 1 Runge Jeffrey W. · CIK 0001479091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2016 Filed Sep 19, 2016 21:47 UTC | Altimmune, Inc. PIP · Entity 5349 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $1.69 | $0.00 |
DisclosureSEC source: 0001144204-16-124477 · v449073_4.xml · derivative · entry 12 Runge Jeffrey W. · CIK 0001479091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2025-08-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2016 Filed Sep 19, 2016 21:47 UTC | Altimmune, Inc. PIP · Entity 5349 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $1.51 | $0.00 |
DisclosureSEC source: 0001144204-16-124477 · v449073_4.xml · derivative · entry 11 Runge Jeffrey W. · CIK 0001479091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2024-06-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2016 Filed Sep 19, 2016 21:47 UTC | Altimmune, Inc. PIP · Entity 5349 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001144204-16-124477 · v449073_4.xml · derivative · entry 10 Runge Jeffrey W. · CIK 0001479091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2023-06-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2016 Filed Sep 19, 2016 21:47 UTC | Altimmune, Inc. PIP · Entity 5349 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $1.45 | $0.00 |
DisclosureSEC source: 0001144204-16-124477 · v449073_4.xml · derivative · entry 9 Runge Jeffrey W. · CIK 0001479091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2022-06-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2016 Filed Sep 19, 2016 21:47 UTC | Altimmune, Inc. PIP · Entity 5349 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001144204-16-124477 · v449073_4.xml · derivative · entry 8 Runge Jeffrey W. · CIK 0001479091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2020-06-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2016 Filed Sep 19, 2016 21:47 UTC | Altimmune, Inc. PIP · Entity 5349 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $1.35 | $0.00 |
DisclosureSEC source: 0001144204-16-124477 · v449073_4.xml · derivative · entry 7 Runge Jeffrey W. · CIK 0001479091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2019-12-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2016 Filed Sep 19, 2016 21:47 UTC | Altimmune, Inc. PIP · Entity 5349 | Exercise / conversionCommon Stock, par value $0.0001 per share | 20,000 | $1.69 | $33,800.00 |
DisclosureSEC source: 0001144204-16-124477 · v449073_4.xml · nonDerivative · entry 6 Runge Jeffrey W. · CIK 0001479091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 157,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2016 Filed Sep 19, 2016 21:47 UTC | Altimmune, Inc. PIP · Entity 5349 | Exercise / conversionCommon Stock, par value $0.0001 per share | 20,000 | $1.51 | $30,200.00 |
DisclosureSEC source: 0001144204-16-124477 · v449073_4.xml · nonDerivative · entry 5 Runge Jeffrey W. · CIK 0001479091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2016 Filed Sep 19, 2016 21:47 UTC | Altimmune, Inc. PIP · Entity 5349 | Exercise / conversionCommon Stock, par value $0.0001 per share | 20,000 | $1.64 | $32,800.00 |
DisclosureSEC source: 0001144204-16-124477 · v449073_4.xml · nonDerivative · entry 4 Runge Jeffrey W. · CIK 0001479091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2016 Filed Sep 19, 2016 21:47 UTC | Altimmune, Inc. PIP · Entity 5349 | Exercise / conversionCommon Stock, par value $0.0001 per share | 20,000 | $1.45 | $29,000.00 |
DisclosureSEC source: 0001144204-16-124477 · v449073_4.xml · nonDerivative · entry 3 Runge Jeffrey W. · CIK 0001479091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2016 Filed Sep 19, 2016 21:47 UTC | Altimmune, Inc. PIP · Entity 5349 | Exercise / conversionCommon Stock, par value $0.0001 per share | 20,000 | $1.60 | $32,000.00 |
DisclosureSEC source: 0001144204-16-124477 · v449073_4.xml · nonDerivative · entry 2 Runge Jeffrey W. · CIK 0001479091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 15, 2016 Filed Sep 19, 2016 21:47 UTC | Altimmune, Inc. PIP · Entity 5349 | Exercise / conversionCommon Stock, par value $0.0001 per share | 20,000 | $1.35 | $27,000.00 |
DisclosureSEC source: 0001144204-16-124477 · v449073_4.xml · nonDerivative · entry 1 Runge Jeffrey W. · CIK 0001479091 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,700 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.